Friday, July 10, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “aspart”

34 pharma patents match "aspart" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 34
Index total 30,257
Page 1 / 2

Quick answer

This filtered view shows 34 pharmaceutical patents matching "aspart" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

34 results for “aspart” · 30,257 patents in full index Clear search

  1. US 12325732

    Pro-insulin aspart structure and method for preparing insulin aspart

    AMPHASTAR NANJING PHARMACEUTICALS INC · Granted Jun 10, 2025 · Expires Jun 5, 2045

    granted

  2. US 11166924

    N-methyl-d-aspartate receptor allosteric modulators and methods for their use

    Qingdao Primedicine Pharmaceutical Company, Ltd. · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted

  3. US 8937093

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 20, 2015 · Expires Jan 15, 2035

    granted

  4. US 8778980

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted

  5. US 8722708

    Substituted isoindolines as aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 13, 2014 · Expires May 8, 2034

    granted

  6. US 8691831

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted

  7. US 8455497

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jun 4, 2013 · Expires May 30, 2033

    granted

  8. US 8242112

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted

  9. US 8178513

    Heterocyclic aspartyl protease inhibitors

    Pharmacopeia Drug Discovery, Inc. · Granted May 15, 2012 · Expires May 10, 2032

    granted

  10. US 7919523

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2011 · Expires Mar 31, 2031

    granted

  11. US 7608632

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 27, 2009 · Expires Oct 22, 2029

    granted

  12. US 7592368

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Sep 22, 2009 · Expires Sep 17, 2029

    granted

  13. US 7442718

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Oct 28, 2008 · Expires Oct 23, 2028

    granted

  14. US 7419967

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted

  15. US 7321063

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Jan 22, 2008 · Expires Jan 17, 2028

    granted

  16. US 7132420

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 7, 2006 · Expires Nov 2, 2026

    granted

  17. US 7119105

    Methods for treating neurodegenerative disorders using aspartyl protease inhibitors

    The Regents of the University of California · Granted Oct 10, 2006 · Expires Oct 5, 2026

    granted

  18. US 6878728

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 12, 2005 · Expires Apr 7, 2025

    expired

  19. US 6838474

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2005 · Expires Dec 30, 2024

    expired

  20. US 6720335

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 13, 2004 · Expires Apr 8, 2024

    expired

  21. US 6617350

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 9, 2003 · Expires Sep 4, 2023

    expired

  22. US 6613764

    Aspartic protease inhibitors

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  23. US 6613743

    Sulfonamide inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Sep 2, 2003 · Expires Aug 28, 2023

    expired

  24. US 6559137

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 6, 2003 · Expires May 1, 2023

    expired

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.